Agios Pharmaceuticals (AGIO) Inventory (2018 - 2026)

Agios Pharmaceuticals has reported Inventory for 8 years, with the latest figure at $35.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 18.52% year-over-year to $35.1 million; the trailing twelve-month figure through Mar 2026 stood at $35.1 million (up 18.52% YoY), and the FY2025 full-year result was $32.9 million, up 19.21% from the prior year.
• Inventory for Q1 2026 stood at $35.1 million, up from $32.9 million in the prior quarter.
• The five-year high for Inventory was $35.1 million in Q1 2026, with the low at $2.5 million in Q1 2022.
• Historically, Inventory has averaged $20.3 million across 5 years, with a median of $23.1 million in 2024.
• Annual changes were most pronounced in 2023 — Inventory jumped 357.71% — and 2026, when it rose 18.52%.
• Agios Pharmaceuticals' Inventory stood at $8.5 million in 2022, then jumped by 124.63% to $19.1 million in 2023, then surged by 44.77% to $27.6 million in 2024, then grew by 19.21% to $32.9 million in 2025, then advanced by 6.58% to $35.1 million in 2026.
• The last three Inventory figures came in at $35.1 million (Q1 2026), $32.9 million (Q4 2025), and $32.0 million (Q3 2025), per Business Quant data.